Literature DB >> 25331158

Recent trends in the incidence of testicular germ cell tumors in the United States.

A A Ghazarian1, B Trabert, S S Devesa, K A McGlynn.   

Abstract

Testicular germ cell tumors (TGCT), which comprise 98% of all testicular malignancies, are the most commonly occurring cancers among men between the ages of 15 and 44 years in the United States (US). A prior report from our group found that while TGCT incidence among all US men increased between 1973 and 2003, the rate of increase among black men was more pronounced starting in 1989-1993 than was the rate of increase among other men. In addition, TGCT incidence increased among Hispanic white men between 1992 and 2003. To determine whether these patterns have continued, in the current study, we examined temporal trends in incidence through 2011. Between 1992 and 2011, 21 271 TGCTs (12 419 seminomas; 8715 non-seminomas; 137 spermatocytic seminomas) were diagnosed among residents of the Surveillance, Epidemiology, and End Results 13 registry areas. The incidence of TGCT was highest among non-Hispanic white men (6.97 per 100 000 man-years) followed by American Indian/Alaska Native (AI/AN; 4.66), Hispanic white (4.11), Asian/Pacific Islander (A/PI; 1.95), and black (1.20) men. Non-Hispanic white men were more likely to present with smaller tumors (3.5 cm) and localized disease (72.6%) than were men of other races/ethnicities. Between 1992 and 2011, TGCT incidence increased significantly among Hispanic white [annual percent change (APC) = 2.94, p < 0.0001], black (APC = 1.67, p = 0.03), non-Hispanic white (APC = 1.23, p < 0.0001), and A/PI (APC = 1.04, p = 0.05) men. Incidence rates also increased, although not significantly, among AI/AN men (APC = 2.96, p = 0.06). The increases were greater for non-seminoma than seminoma. In summary, while non-Hispanic white men in the US continue to have the highest incidence of TGCT, they present at more favorable stages of disease and with smaller tumors than do other men. The increasing rates among non-white men, in conjunction with the larger proportion of non-localized stage disease, suggest an area where future research is warranted. Published 2014. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  ethnic groups; incidence; testicular cancer; testicular germ cell tumor; trends

Mesh:

Year:  2014        PMID: 25331158      PMCID: PMC4342271          DOI: 10.1111/andr.288

Source DB:  PubMed          Journal:  Andrology        ISSN: 2047-2919            Impact factor:   3.842


  21 in total

Review 1.  A systematic review and meta-analysis of perinatal variables in relation to the risk of testicular cancer--experiences of the son.

Authors:  Michael B Cook; Olof Akre; David Forman; M Patricia Madigan; Lorenzo Richiardi; Katherine A McGlynn
Journal:  Int J Epidemiol       Date:  2010-07-26       Impact factor: 7.196

Review 2.  A systematic review and meta-analysis of perinatal variables in relation to the risk of testicular cancer--experiences of the mother.

Authors:  Michael B Cook; Olof Akre; David Forman; M Patricia Madigan; Lorenzo Richiardi; Katherine A McGlynn
Journal:  Int J Epidemiol       Date:  2009-09-23       Impact factor: 7.196

3.  International trends in the incidence of testicular cancer, 1973-2002.

Authors:  Victoria M Chia; Sabah M Quraishi; Susan S Devesa; Mark P Purdue; Michael B Cook; Katherine A McGlynn
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-05       Impact factor: 4.254

4.  Increase in testicular germ cell tumor incidence among Hispanic adolescents and young adults in the United States.

Authors:  Franklin L Chien; Stephen M Schwartz; Rebecca H Johnson
Journal:  Cancer       Date:  2014-07-14       Impact factor: 6.860

Review 5.  Familial testicular germ cell tumours.

Authors:  Christian P Kratz; Phuong L Mai; Mark H Greene
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2010-06       Impact factor: 4.690

6.  Disparities in stage at diagnosis among adults with testicular germ cell tumors in the National Cancer Data Base.

Authors:  Catherine C Lerro; Anthony S Robbins; Stacey A Fedewa; Elizabeth M Ward
Journal:  Urol Oncol       Date:  2013-02-08       Impact factor: 3.498

7.  Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer.

Authors:  Clare Turnbull; Elizabeth A Rapley; Sheila Seal; David Pernet; Anthony Renwick; Deborah Hughes; Michelle Ricketts; Rachel Linger; Jeremie Nsengimana; Panagiotis Deloukas; Robert A Huddart; D Timothy Bishop; Douglas F Easton; Michael R Stratton; Nazneen Rahman
Journal:  Nat Genet       Date:  2010-06-13       Impact factor: 38.330

8.  Testicular germ cell tumor susceptibility associated with the UCK2 locus on chromosome 1q23.

Authors:  Fredrick R Schumacher; Zhaoming Wang; Rolf I Skotheim; Roelof Koster; Charles C Chung; Michelle A T Hildebrandt; Christian P Kratz; Anne C Bakken; D Timothy Bishop; Michael B Cook; R Loren Erickson; Sophie D Fosså; Mark H Greene; Kevin B Jacobs; Peter A Kanetsky; Laurence N Kolonel; Jennifer T Loud; Larissa A Korde; Loic Le Marchand; Juan Pablo Lewinger; Ragnhild A Lothe; Malcolm C Pike; Nazneen Rahman; Mark V Rubertone; Stephen M Schwartz; Kimberly D Siegmund; Eila C Skinner; Clare Turnbull; David J Van Den Berg; Xifeng Wu; Meredith Yeager; Katherine L Nathanson; Stephen J Chanock; Victoria K Cortessis; Katherine A McGlynn
Journal:  Hum Mol Genet       Date:  2013-03-05       Impact factor: 6.150

9.  Identification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14.

Authors:  Elise Ruark; Sheila Seal; Heather McDonald; Feng Zhang; Anna Elliot; Kingwai Lau; Elizabeth Perdeaux; Elizabeth Rapley; Rosalind Eeles; Julian Peto; Zsofia Kote-Jarai; Kenneth Muir; Jeremie Nsengimana; Janet Shipley; D Timothy Bishop; Michael R Stratton; Douglas F Easton; Robert A Huddart; Nazneen Rahman; Clare Turnbull
Journal:  Nat Genet       Date:  2013-05-12       Impact factor: 38.330

10.  Meta-analysis identifies four new loci associated with testicular germ cell tumor.

Authors:  Charles C Chung; Peter A Kanetsky; Zhaoming Wang; Michelle A T Hildebrandt; Roelof Koster; Rolf I Skotheim; Christian P Kratz; Clare Turnbull; Victoria K Cortessis; Anne C Bakken; D Timothy Bishop; Michael B Cook; R Loren Erickson; Sophie D Fosså; Kevin B Jacobs; Larissa A Korde; Sigrid M Kraggerud; Ragnhild A Lothe; Jennifer T Loud; Nazneen Rahman; Eila C Skinner; Duncan C Thomas; Xifeng Wu; Meredith Yeager; Fredrick R Schumacher; Mark H Greene; Stephen M Schwartz; Katherine A McGlynn; Stephen J Chanock; Katherine L Nathanson
Journal:  Nat Genet       Date:  2013-05-12       Impact factor: 38.330

View more
  37 in total

1.  "Off-Label" Usage of Testicular Self-Examination (TSE): Benefits Beyond Cancer Detection.

Authors:  Michael J Rovito; James E Leone; Chase T Cavayero
Journal:  Am J Mens Health       Date:  2015-05-19

2.  Future of testicular germ cell tumor incidence in the United States: Forecast through 2026.

Authors:  Armen A Ghazarian; Scott P Kelly; Sean F Altekruse; Philip S Rosenberg; Katherine A McGlynn
Journal:  Cancer       Date:  2017-02-27       Impact factor: 6.860

Review 3.  Genetic changes associated with testicular cancer susceptibility.

Authors:  Louise C Pyle; Katherine L Nathanson
Journal:  Semin Oncol       Date:  2016-09-20       Impact factor: 4.929

4.  Increasing Incidence of Testicular Germ Cell Tumors among Racial/Ethnic Minorities in the United States.

Authors:  Armen A Ghazarian; Katherine A McGlynn
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-05-08       Impact factor: 4.254

5.  Testicular function among testicular cancer survivors treated with cisplatin-based chemotherapy.

Authors:  Takeshi Namekawa; Takashi Imamoto; Mayuko Kato; Tomokazu Sazuka; Miki Fuse; Shinichi Sakamoto; Koji Kawamura; Tomohiko Ichikawa
Journal:  Reprod Med Biol       Date:  2015-12-31

6.  Cannabis Use and Incidence of Testicular Cancer: A 42-Year Follow-up of Swedish Men between 1970 and 2011.

Authors:  Russell C Callaghan; Peter Allebeck; Olof Akre; Katherine A McGlynn; Anna Sidorchuk
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-11       Impact factor: 4.254

7.  Incidence of testicular germ cell tumors among US men by census region.

Authors:  Armen A Ghazarian; Britton Trabert; Barry I Graubard; Stephen M Schwartz; Sean F Altekruse; Katherine A McGlynn
Journal:  Cancer       Date:  2015-08-17       Impact factor: 6.860

8.  Urological second malignant neoplasms in testicular nonseminoma survivors: a population-based analysis.

Authors:  Hao Li; Chenxing Zhu; Jiapei Wu; Yuchen Ma; Xi Jin; Xin Wei; Kunjie Wang; Hong Li
Journal:  Int Urol Nephrol       Date:  2020-10-14       Impact factor: 2.370

Review 9.  Recommendations for followup of stage I and II seminoma: The Princess Margaret Cancer Centre approach.

Authors:  Hester Lieng; Padraig Warde; Philippe Bedard; Robert J Hamilton; Aaron R Hansen; Michael A S Jewett; Martin O'malley; Joan Sweet; Peter Chung
Journal:  Can Urol Assoc J       Date:  2017-12-01       Impact factor: 1.862

10.  Cumulative Burden of Morbidity Among Testicular Cancer Survivors After Standard Cisplatin-Based Chemotherapy: A Multi-Institutional Study.

Authors:  Sarah L Kerns; Chunkit Fung; Patrick O Monahan; Shirin Ardeshir-Rouhani-Fard; Mohammad I Abu Zaid; AnnaLynn M Williams; Timothy E Stump; Howard D Sesso; Darren R Feldman; Robert J Hamilton; David J Vaughn; Clair Beard; Robert A Huddart; Jeri Kim; Christian Kollmannsberger; Deepak M Sahasrabudhe; Ryan Cook; Sophie D Fossa; Lawrence H Einhorn; Lois B Travis
Journal:  J Clin Oncol       Date:  2018-04-04       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.